These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27512952)

  • 41. Wnt1 from cochlear schwann cells enhances neuronal differentiation of transplanted neural stem cells in a rat spiral ganglion neuron degeneration model.
    He Y; Zhang PZ; Sun D; Mi WJ; Zhang XY; Cui Y; Jiang XW; Mao XB; Qiu JH
    Cell Transplant; 2014 Apr; 23(6):747-60. PubMed ID: 23809337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
    Nijland PG; Witte ME; van het Hof B; van der Pol S; Bauer J; Lassmann H; van der Valk P; de Vries HE; van Horssen J
    Acta Neuropathol Commun; 2014 Dec; 2():170. PubMed ID: 25492529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. "Supercharged Cells" for delivery of recombinant human iduronate-2-sulfatase.
    Pan D; Jonsson JJ; Braun SE; McIvor RS; Whitley CB
    Mol Genet Metab; 2000 Jul; 70(3):170-8. PubMed ID: 10924271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PINK1 expression increases during brain development and stem cell differentiation, and affects the development of GFAP-positive astrocytes.
    Choi I; Choi DJ; Yang H; Woo JH; Chang MY; Kim JY; Sun W; Park SM; Jou I; Lee SH; Joe EH
    Mol Brain; 2016 Jan; 9():5. PubMed ID: 26746235
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
    Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
    Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of normal and mutant iduronate-2-sulphatase conformation.
    Parkinson-Lawrence E; Turner C; Hopwood J; Brooks D
    Biochem J; 2005 Mar; 386(Pt 2):395-400. PubMed ID: 15500445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Analysis of IDS gene mutation in a family affected with mucopolysaccharidosis typeⅡ].
    Li Y; Mei S; Kong X; Zhao Z; Zhu X; Yang X; Qin Z; Wu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):58-60. PubMed ID: 28186595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nitric oxide mediates glial-induced neurodegeneration in Alexander disease.
    Wang L; Hagemann TL; Kalwa H; Michel T; Messing A; Feany MB
    Nat Commun; 2015 Nov; 6():8966. PubMed ID: 26608817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical, biochemical and molecular characteristics of Filipino patients with mucopolysaccharidosis type II - Hunter syndrome.
    Chiong MA; Canson DM; Abacan MA; Baluyot MM; Cordero CP; Silao CL
    Orphanet J Rare Dis; 2017 Jan; 12(1):7. PubMed ID: 28077157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxygen glucose deprivation-induced astrocyte dysfunction provokes neuronal death through oxidative stress.
    Gouix E; Buisson A; Nieoullon A; Kerkerian-Le Goff L; Tauskela JS; Blondeau N; Had-Aissouni L
    Pharmacol Res; 2014 Sep; 87():8-17. PubMed ID: 24928737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mucopolysaccharidosis type II: identification of 30 novel mutations among Latin American patients.
    Brusius-Facchin AC; Schwartz IV; Zimmer C; Ribeiro MG; Acosta AX; Horovitz D; Monlleó IL; Fontes MI; Fett-Conte A; Sobrinho RP; Duarte AR; Boy R; Mabe P; Ascurra M; de Michelena M; Tylee KL; Besley GT; Garreton MC; Giugliani R; Leistner-Segal S
    Mol Genet Metab; 2014 Feb; 111(2):133-8. PubMed ID: 24125893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclic GMP phosphodiesterase inhibition alters the glial inflammatory response, reduces oxidative stress and cell death and increases angiogenesis following focal brain injury.
    Pifarré P; Prado J; Giralt M; Molinero A; Hidalgo J; Garcia A
    J Neurochem; 2010 Feb; 112(3):807-17. PubMed ID: 20002517
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IDS transfer from overexpressing cells to IDS-deficient cells.
    Millat G; Froissart R; Maire I; Bozon D
    Exp Cell Res; 1997 Feb; 230(2):362-7. PubMed ID: 9024795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sequence of the human iduronate 2-sulfatase (IDS) gene.
    Wilson PJ; Meaney CA; Hopwood JJ; Morris CP
    Genomics; 1993 Sep; 17(3):773-5. PubMed ID: 8244397
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preclinical studies of lymphocyte gene therapy for mild Hunter syndrome (mucopolysaccharidosis type II).
    Braun SE; Pan D; Aronovich EL; Jonsson JJ; McIvor RS; Whitley CB
    Hum Gene Ther; 1996 Feb; 7(3):283-90. PubMed ID: 8835216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene.
    Christianto A; Watanabe H; Nakajima T; Inazu T
    Clin Chim Acta; 2013 Aug; 423():66-8. PubMed ID: 23726270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design and validation of a GMP stem cell manufacturing protocol for MPSII hematopoietic stem cell gene therapy.
    Ellison S; Buckland K; Learmonth Y; Day V; Kalra S; Howe L; Roman-Rodriguez FJ; Bonafont J; Booth L; Holley R; Smythe J; Jones S; Thrasher A; Booth C; Bigger BW
    Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101271. PubMed ID: 38946936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammation Promotes a Conversion of Astrocytes into Neural Progenitor Cells via NF-κB Activation.
    Gabel S; Koncina E; Dorban G; Heurtaux T; Birck C; Glaab E; Michelucci A; Heuschling P; Grandbarbe L
    Mol Neurobiol; 2016 Oct; 53(8):5041-55. PubMed ID: 26381429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modelling the neuropathology of lysosomal storage disorders through disease-specific human induced pluripotent stem cells.
    Kobolák J; Molnár K; Varga E; Bock I; Jezsó B; Téglási A; Zhou S; Lo Giudice M; Hoogeveen-Westerveld M; Pijnappel WP; Phanthong P; Varga N; Kitiyanant N; Freude K; Nakanishi H; László L; Hyttel P; Dinnyés A
    Exp Cell Res; 2019 Jul; 380(2):216-233. PubMed ID: 31039347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perturbations in cell signaling elicit early cardiac defects in mucopolysaccharidosis type II.
    Costa R; Urbani A; Salvalaio M; Bellesso S; Cieri D; Zancan I; Filocamo M; Bonaldo P; Szabò I; Tomanin R; Moro E
    Hum Mol Genet; 2017 May; 26(9):1643-1655. PubMed ID: 28334757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.